nucleos(t)ide analogues - Globe Thesis

Keyword [nucleos(t)ide analogues] Result: 41 - 60 \| Page: 3 of 4
41.	Relationship Between MicroRNA-122 And Virological Response In Chronic Hepatitis B Patients
42.	Long-term Antiviral Efficacy Of Nucleos(t)ide Analogues In Prospective Cohort Of Patients With Chronic Hepatitis B And Quasispecies Heterogeneity And Evolutionary Mechanism Of Hepatitis B Virus
43.	Diagnostic Value Of FibroScan And FibroScan Combined With Serological Markers For Liver Fibrosis In Chronic Hepatitis B Patients
44.	Clinical Characteristics And Antiviral Effect On Chronic Hepatitis B Patients With Pre-existing RtA181 Mutation
45.	Effects Of Chronic Hepatitis B Patients With Nucleos(t)ide Analogues Treatment
46.	Long-term Effects Of Nucleoside (Acid) Drugs On The Reversal Of HePatitis B Cirrhosis
47.	Risk Factors Associated With Progression To Acute-on-chronic Liver Failure In Patients With Chronic Hepatitis B During Hepatitis Relapse After Nucleos(t)ide Analogues Withdrawal
48.	Corelation Between CXCL13/CXCR5 Expression And Clinical Relapse After Nucleos(t)ide Analogue Discontinuation In Chronic Hepatitis B Patients
49.	Nucleos(t)ide Analogues Improved Survival Of CHB-related HCC Patients And IL-34 With CHB Related Liver Disease
50.	Long-term Outcome And Cost-effectiveness Of Antiviral Treatment In Chronic Hepatitis B Patients
51.	Analysis Of Influencing Factors Of Virological Breakthrough And Virological Response In Patients With Chronic Hepatitis B
52.	Analysis Of Variation After Treatment With Nucleos(t) Ide Analogue In Patients With Chronic Hepatitis B
53.	Effects Of IFN Combined With Nas Therapy In HBeAg-positive Chronic Hepatitis B:A Meta-analysys
54.	Changes In HBsAg Quantification After HBV DNA Below The Lowest Limit Of Detection In Patients With Chronic Hepatitis B Treated With Nucleos(t)ide Analogues
55.	Application Of Serum HBV RNA To Predict The Antiviral Response Of Nucleos(t)ide Analogues
56.	Peg IFN-? Treatment Enhanced The Inhibitory Effect Of NK Cells On Treg In Nucleos(t)ide Analogues-treated Patients With Chronic Hepatitis B
57.	Treatment Efficacy And Related Factors Of Nucleos(t)ide Analogues In Patients With CHB And Related Liver Fibrosis
58.	Characteristics And Related Factors For Chronic Hepatitis B Patients With Low-level Viremia After NAs Treatment ��A Single-center Cross-sectional Retrospective Study
59.	Hepatitis B Surface Antigen Kinetics After Discontinuation Of Nucleos(t)ide Analogues Treatment In Non-cirrhotic HBeAg-positive Chronic Hepatitis B
60.	Analysis Of Early Renal Function Damage In Patients With Chronic Hepatitis B Treated With Nucleos(t)ide Analogues
<<First <Prev Next> Last>> Jump to